Phosplatin therapeutics is a clinical stage pharmaceutical company founded by two entrepreneurs, based on over twenty years of work by the inventor. We are currently developing phosphaplatins, a family of rationally designed small-molecule agents for the treatment of cancer.
The lead agent, pt-112, combines apoptotic and immunogenic properties in combating cancer, along with an exceptional tolerability profile. It was rationa...
Phosplatin therapeutics is a clinical stage pharmaceutical company founded by two entrepreneurs, based on over twenty years of work by the inventor. We are currently developing phosphaplatins, a family of rationally designed small-molecule agents for the treatment of cancer.
The lead agent, pt-112, combines apoptotic and immunogenic properties in combating cancer, along with an exceptional tolerability profile. It was rationally designed to avoid the toxicity and drug resistance mechanisms common to conventional chemotherapy. Because of its unique properties, pt-112 is being investigated in both solid tumors & hematological malignancies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.